Daniel J. O'Connor

This profile gathers the share dealings of Daniel J. O'Connor across 5 companies, led by Ambrx Biopharma, Inc., ZyVersa Therapeutics, Inc. and Ambrx Biopharma Inc. We count 8 filings; the first trade dates from 30 April 2021 and the latest from 7 March 2024.

On the open market, the record shows 1 purchase and 2 sales worth €478k. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants.

Most recently, on 7 March 2024, the filings show a transaction in Ambrx Biopharma, Inc. The last purchase on record was published on 2 June 2022, which is 1,599 days ago. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.